With a major breakthrough in psychedelic medicine, Compass Pathways' psilocybin-based therapy, COMP360, has delivered compelling Phase 3 results, sending shockwaves through the biopharma world and reigniting hope for patients with treatment-resistant depression. To unpack what this means for
The journey through pediatric cancer treatment is a formidable one, marked not only by rigorous medical procedures but also by the often-unseen burdens of persistent pain, anxiety, and profound emotional distress. For countless children and their families, these psychological challenges are a daily
For many individuals diagnosed with life-threatening blood cancers, the search for a suitable stem cell donor becomes a desperate race against time, a journey where hope can dwindle with each passing day that a match is not found. The standard of care, an allogeneic stem cell transplant, relies
The aftermath of a spinal cord injury unleashes a devastating and prolonged biological assault, where the secondary damage cascade often proves more destructive than the initial physical trauma. This secondary injury process is a complex storm of excessive reactive oxygen species, relentless
A comprehensive global analysis has uncovered a troubling paradox in the fight against early-onset gastric cancer, a form of the disease striking individuals under the age of 50. While worldwide mortality rates have been steadily decreasing for decades, this positive trend masks a deepening and
In the complex world of health and longevity, the simple advice to "eat better" often feels vague. To bring clarity to this crucial topic, we sat down with biopharma expert Ivan Kairatov, whose extensive background in research and development provides a unique lens on the interplay between diet,
